Pulmonx's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pulmonx's ROI in the second quarter of 2026?
Pulmonx Corporation recorded a cumulative net loss of $-48 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -45.82%.

Within the Healthcare sector 118 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3614 to 3619.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-21.94 %	-20.92 %	-19.07 %	-16.59 %	-13.23 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	94	101	109	115	125
Return On Investment (TTM)	-45.82 %	-47.25 %	-45.46 %	-45.01 %	-42.33 %
LUNG's Overall Ranking	# 3619	# 3614	# 2617	# 3244	# 3271
Seq. Investment Change TTM	-6.75 %	-5.2 %	-5.79 %	-6.26 %	-5.54 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-48	-53	-54	-57	-57

LUNG Company Profile >> Back to LUNG Roi Comparisons >> See Annual LUNG Return On Investment

Return On Investment LUNG's Ranking
Within:	No.
Industry	# 41
Sector	# 119
Overall	# 3619

Return On Investment Statistics
High	Average	Low
-12.51 %	-33 %	-47.25 %
(Jun 30 2021)		(Mar 31 2026)

Financial Statements
Pulmonx's II. Quarter Investments	$ 94 Millions	LUNG's Balance sheet
Pulmonx's II. Quarter Income	$ -10 Millions	Quarterly LUNG's Income Statement
LUNG's Income by Division		See LUNG's Income by Division

LUNG Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	109	138	155	175	218
Y / Y Investment Growth	-21.08 %	-10.48 %	-11.74 %	-19.5 %	-13.36 %
Net Income in Millions	-54	-56	-61	-59	-49
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-49.44 %	-40.74 %	-39.35 %	-33.63 %	-22.36 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LUNG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LUNG's Competitors
Subscribers only: Roi for Pulmonx's Suppliers
Subscribers only: Return On Investment for LUNG's Customers

Other Ratios
LUNG's Roa	LUNG's Inventory Turnover Ratio	LUNG's Growth Rates	LUNG's Dividend Statistics
	LUNG's Profitability Ratios	LUNG's Asset Turnover Ratio	LUNG's Dividend Growth
LUNG's Roe	LUNG's Valuation Ratios	LUNG's Financial Strength Ratios	LUNG's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:38:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.